Buprenorphine treatment at syringe exchanges to reduce opioid misuse and HIV risk

Project: Research project

Project Details

Description

Project Narrative: Our project seeks to increase engagement in opioid use disorder treatment by having syringe exchange participants initiate buprenorphine treatment onsite at syringe exchange programs. Over two weeks, participants in the onsite buprenorphine treatment intervention will see a buprenorphine provider twice, receive weekly blister packs of medication, and then their care will be transferred to a community health center for maintenance treatment. By improving engagement in buprenorphine treatment, this proposal has the potential to reduce HIV risk behaviors, illicit opioid use, overdose-related deaths, which would have broad public health impact.
StatusActive
Effective start/end date8/1/172/28/23

Funding

  • National Institute on Drug Abuse: $598,913.00
  • NATIONAL INSTITUTE ON DRUG ABUSE: $721,387.00
  • NATIONAL INSTITUTE ON DRUG ABUSE: $723,410.00
  • National Institute on Drug Abuse: $93,845.00
  • NATIONAL INSTITUTE ON DRUG ABUSE: $454,931.00
  • National Institute on Drug Abuse: $719,596.00
  • National Institute on Drug Abuse: $103,720.00
  • NATIONAL INSTITUTE ON DRUG ABUSE: $264,665.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.